125 related articles for article (PubMed ID: 10683762)
1. ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells.
Lee CH; Yun HJ; Kang HS; Kim HD
IUBMB Life; 1999 Dec; 48(6):585-91. PubMed ID: 10683762
[TBL] [Abstract][Full Text] [Related]
2. K562 cells resistant to phorbol 12-myristate 13-acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Egr-1 expression from megakaryocyte differentiation.
Shelly C; Petruzzelli L; Herrera R
Cell Growth Differ; 2000 Sep; 11(9):501-6. PubMed ID: 11007455
[TBL] [Abstract][Full Text] [Related]
3. PKC pathway and ERK/MAPK pathway are required for induction of cyclin D1 and p21Waf1 during 12-o-tetradecanoylphorbol 13-acetate-induced differentiation of myeloleukemia cells.
Matsumoto E; Hatanaka M; Bohgaki M; Maeda S
Kobe J Med Sci; 2006; 52(6):181-94. PubMed ID: 17329956
[TBL] [Abstract][Full Text] [Related]
4. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells.
Ichimura A; Ruike Y; Terasawa K; Shimizu K; Tsujimoto G
Mol Pharmacol; 2010 Jun; 77(6):1016-24. PubMed ID: 20299489
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase/90-KDA ribosomal S6 kinase/nuclear factor-kappa B pathway mediates phorbol 12-myristate 13-acetate-induced megakaryocytic differentiation of K562 cells.
Kim KW; Kim SH; Lee EY; Kim ND; Kang HS; Kim HD; Chung BS; Kang CD
J Biol Chem; 2001 Apr; 276(16):13186-91. PubMed ID: 11278385
[TBL] [Abstract][Full Text] [Related]
8. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
9. Inducible expression of the megakaryocyte-specific gene glycoprotein IX is mediated through an Ets binding site and involves upstream activation of extracellular signal-regulated kinase.
Eisbacher M; Khachigian LM; Khin TH; Holmes ML; Chong BH
Cell Growth Differ; 2001 Aug; 12(8):435-45. PubMed ID: 11504709
[TBL] [Abstract][Full Text] [Related]
10. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle- and protein kinase C-specific effects of resiniferatoxin and resiniferonol 9,13,14-ortho-phenylacetate in intestinal epithelial cells.
Frey MR; Clark JA; Bateman NW; Kazanietz MG; Black AR; Black JD
Biochem Pharmacol; 2004 May; 67(10):1873-86. PubMed ID: 15130764
[TBL] [Abstract][Full Text] [Related]
12. Involvement of ERK/MAPK pathway in megakaryocytic differentiation of K562 cells induced by 3-hydrogenkwadaphnin.
Meshkini A; Yazdanparast R
Toxicol In Vitro; 2008 Sep; 22(6):1503-10. PubMed ID: 18586450
[TBL] [Abstract][Full Text] [Related]
13. Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by cardiotoxin III (Naja naja atra) in K562 leukemia cells.
Yang SH; Chien CM; Chang LS; Lin SR
Toxicon; 2007 Jun; 49(7):966-74. PubMed ID: 17368702
[TBL] [Abstract][Full Text] [Related]
14. Ectopic cyclin D1 expression blocks STI571-induced erythroid differentiation of K562 cells.
Kawano T; Horiguchi-Yamada J; Saito S; Iwase S; Furukawa Y; Kano Y; Yamada H
Leuk Res; 2004 Jun; 28(6):623-9. PubMed ID: 15120940
[TBL] [Abstract][Full Text] [Related]
15. Lactosylceramide alpha2,3-sialyltransferase is induced via a PKC/ERK/CREB-dependent pathway in K562 human leukemia cells.
Choi HJ; Park YG; Kim CH
Mol Cells; 2007 Apr; 23(2):138-44. PubMed ID: 17464189
[TBL] [Abstract][Full Text] [Related]
16. The protein tyrosine phosphatase HePTP regulates nuclear translocation of ERK2 and can modulate megakaryocytic differentiation of K562 cells.
Pettiford SM; Herbst R
Leukemia; 2003 Feb; 17(2):366-78. PubMed ID: 12592337
[TBL] [Abstract][Full Text] [Related]
17. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
[TBL] [Abstract][Full Text] [Related]
18. [Effects of mitogen-activated protein kinase on phorbol 12-myristate 13-acetate-induced matrix metalloproteinase-9 gene expression in cytotrophoblastic cells].
Zhang XQ; Huang LP; Zhao XS; Li H; Chen SL; Xing FQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):282-5. PubMed ID: 15041541
[TBL] [Abstract][Full Text] [Related]
19. Signaling mechanism of PMA-induced differentiation of K562 cells.
Kang CD; Lee BK; Kim KW; Kim CM; Kim SH; Chung BS
Biochem Biophys Res Commun; 1996 Apr; 221(1):95-100. PubMed ID: 8660351
[TBL] [Abstract][Full Text] [Related]
20. Autocrine stimulation of IGF1 in estrogen-induced growth of endometrial carcinoma cells: involvement of the mitogen-activated protein kinase pathway followed by up-regulation of cyclin D1 and cyclin E.
Kashima H; Shiozawa T; Miyamoto T; Suzuki A; Uchikawa J; Kurai M; Konishi I
Endocr Relat Cancer; 2009 Mar; 16(1):113-22. PubMed ID: 18852162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
